Aspirin for the primary prevention of vascular events?

Public Health

Volumn 123, Issue 12, 2009, Pages 787-788

  Morgan, G ^a  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CARDIOVASCULAR DISEASE; DISEASE TREATMENT; DRUG; PUBLIC HEALTH;

AGING; ARTICLE; BEDTIME DOSAGE; BLEEDING DISORDER; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BREAST CANCER; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIET; DRUG FATALITY; DRUG INFORMATION; EXERCISE; GOVERNMENT REGULATION; HEALTH CARE COST; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MORTALITY; PRIMARY PREVENTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SMOKING CESSATION; UNITED KINGDOM; VASCULAR DISEASE;

ADULT; ASPIRIN; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HUMANS; MIDDLE AGED; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 73349100646     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2009.10.007     Document Type: Article

References (10)

1. Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373 (2009) 1849-1860
2. St Elsewhere's NHS Trust. UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood (2007), British Society of Gastroenterology, London, UK. http://www.bsg.org.uk/clinical/general/uk-upper-gi-bleeding-audit.html (last accessed 07/09/2009)
3. Bulugahapitiya U., Siyambalapitiya S., Sithole J., Fernando D.J., and Idris I. Age threshold for vascular prophylaxis by aspirin in patients without diabetes. Heart 94 (2008) 1429-1432
4. Sattar N., Murray H.M., Welsh P., Blauw G.J., and Buckley B.M. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?. PLoS Med 6 (2009) e1000099
5. Rothwell P.M., Coull A.J., Silver L.E., Fairhead J.F., Giles M.F., Lovelock C.E., et al. Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366 (2005) 1753-1754
6. Gøtzsche P.C., Hartling O.J., Nielsen M., Brodersen J., and Jørgensen K.J. Breast cancer screening: the facts - or maybe not. BMJ 338 (2009) b86
7. Longley M. Elwood P. My health: whose responsibility? A jury decides. J Epidemiol Community Health (in press).
8. Hermida R.C., Avala D.E., Mojon A., and Fernandez J.R. Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertension 22 8 (2009) 896-903
9. International consensus statement on aspirin and NSAIDs for cancer prevention. Lancet Oncol 10 (2009) 501-507
10. Morgan G.P. Ethical considerations in relation to aspirin prophylaxis. Qual Prim Care 6 (2008) 433-440